Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 19/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | PTAFR | P25105 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13200613 | 1.00 | TACR1 (0.45) | TACR1SIGMAR1PTAFRCYP3A4 | |
| SCHEMBL13200543 | 0.92 | TACR1 (0.56) | TACR1SIGMAR1PTAFRCYP3A4 | |
| SCHEMBL2802424 | 0.89 | TACR1 (0.47) | TACR1SIGMAR1PTAFRCYP3A4 | |
| SCHEMBL13200935 | 0.89 | TACR1 (0.47) | TACR1SIGMAR1PTAFRCYP3A4 | |
| SCHEMBL13200863 | 0.86 | TACR1 (0.44) | TACR1SIGMAR1PTAFRCYP3A4 | |
| SCHEMBL2898138 | 0.86 | TACR1 (0.44) | TACR1SIGMAR1PTAFRCYP3A4 | |
| SCHEMBL2851158 | 0.86 | TACR1 (0.44) | TACR1SIGMAR1PTAFRCYP3A4 | |
| SCHEMBL2801048 | 0.83 | TACR1 (0.51) | TACR1SIGMAR1PTAFRCYP3A4 | |
| SCHEMBL13200614 | 0.83 | TACR1 (0.51) | TACR1SIGMAR1PTAFRCYP3A4 | |
| SCHEMBL13201186 | 0.82 | TACR1 (0.53) | TACR1SIGMAR1PTAFRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2170064-A1 | 6.5-PYRROLOPIPERIDINE TACHYKININ RECEPTOR ANTAGONISTS | Merck Sharp & Dohme Corp. (US) | 2010-04-07 | — | — | EP | disclosed |
| WO-2009002770-A1 | 6.5-PYRROLOPIPERIDINE TACHYKININ RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2008-12-31 | — | — | WO | disclosed |